The overall mutation-positive rate for breast cancer susceptibility genes for patients with no prior BRCA1/2 testing reported was 18.1% (N = 64/354), with 1.1% (n = 4) of patients carrying pathogenic variants in two different breast cancer genes. This evidence concerns the gene BRCA1 and breast carcinoma.